SE9300977D0 - Foerfarande foer framstaellning av mellanprodukter avsedda foer framstaellning av antihyperkolesterolemiska medel - Google Patents

Foerfarande foer framstaellning av mellanprodukter avsedda foer framstaellning av antihyperkolesterolemiska medel

Info

Publication number
SE9300977D0
SE9300977D0 SE19939300977A SE9300977A SE9300977D0 SE 9300977 D0 SE9300977 D0 SE 9300977D0 SE 19939300977 A SE19939300977 A SE 19939300977A SE 9300977 A SE9300977 A SE 9300977A SE 9300977 D0 SE9300977 D0 SE 9300977D0
Authority
SE
Sweden
Prior art keywords
preparation
agents
esterolemic
antihypercol
procedures
Prior art date
Application number
SE19939300977A
Other languages
English (en)
Other versions
SE9300977L (sv
SE512485C2 (sv
Inventor
J *Wright John
*Sit Sing-Yuen
*Balasubramanian Neelakantan
J *Brown Peter
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of SE9300977L publication Critical patent/SE9300977L/xx
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of SE9300977D0 publication Critical patent/SE9300977D0/sv
Publication of SE512485C2 publication Critical patent/SE512485C2/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE9300977A 1987-02-25 1993-03-24 Förfarande för framställning av mellanprodukter avsedda för framställning av antihyperkolesterolemiska medel SE512485C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1855887A 1987-02-25 1987-02-25
US07/151,512 US4898949A (en) 1987-02-25 1988-02-18 Intermediates for the preparation of antihypercholesterolemic tetrazole compounds

Publications (3)

Publication Number Publication Date
SE9300977L SE9300977L (sv)
SE9300977D0 true SE9300977D0 (sv) 1993-03-24
SE512485C2 SE512485C2 (sv) 2000-03-20

Family

ID=26691250

Family Applications (3)

Application Number Title Priority Date Filing Date
SE8800637A SE504553C2 (sv) 1987-02-25 1988-02-24 Mellanprodukter och förfaranden för framställning av antihyperkolesterolemiska tetrazolföreningar
SE9300976A SE503201C2 (sv) 1987-02-25 1993-03-24 Tetrazol mellanprodukter för användning för framställning av nya inhibitorer för enzymet HMG-CoA-reduktas
SE9300977A SE512485C2 (sv) 1987-02-25 1993-03-24 Förfarande för framställning av mellanprodukter avsedda för framställning av antihyperkolesterolemiska medel

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE8800637A SE504553C2 (sv) 1987-02-25 1988-02-24 Mellanprodukter och förfaranden för framställning av antihyperkolesterolemiska tetrazolföreningar
SE9300976A SE503201C2 (sv) 1987-02-25 1993-03-24 Tetrazol mellanprodukter för användning för framställning av nya inhibitorer för enzymet HMG-CoA-reduktas

Country Status (27)

Country Link
US (1) US4898949A (sv)
JP (1) JP2603284B2 (sv)
KR (1) KR960007167B1 (sv)
CN (1) CN1030077C (sv)
AT (1) AT395588B (sv)
AU (1) AU610562B2 (sv)
BE (1) BE1002115A3 (sv)
CA (1) CA1328269C (sv)
CH (1) CH678182A5 (sv)
DE (1) DE3805789C2 (sv)
DK (2) DK97388A (sv)
ES (1) ES2009547A6 (sv)
FI (1) FI96600C (sv)
FR (1) FR2611201B1 (sv)
GB (1) GB2202845B (sv)
GR (1) GR1000473B (sv)
HU (3) HU201534B (sv)
IE (1) IE61608B1 (sv)
IT (1) IT1216752B (sv)
LU (1) LU87143A1 (sv)
MY (1) MY102290A (sv)
NL (1) NL8800468A (sv)
NO (1) NO178432C (sv)
NZ (1) NZ223621A (sv)
PT (1) PT86821B (sv)
SE (3) SE504553C2 (sv)
YU (1) YU46781B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
FI94339C (sv) 1989-07-21 1995-08-25 Warner Lambert Co Förfarande för framställning av farmaceutiskt användbar /R-(R*,R*)/-2-(4-fluorfenyl)- , -dihydroxi-5-(1-metyletyl)-3-fenyl-4-/(fenylamino)karbonyl/-1H-pyrrol-1-heptansyra och farmaceutiskt användbara salter därav
US5260325A (en) * 1991-08-19 1993-11-09 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking tertiary amides
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
KR100681366B1 (ko) * 1997-12-19 2007-02-12 워너-램버트 익스포트 리미티드 1,3-디올의 합성방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160100A (en) * 1973-03-23 1979-07-03 American Home Products Corporation Oxamic acid derivatives
US4013647A (en) * 1976-03-23 1977-03-22 American Home Products Corporation Morpholine containing tetrazole-5-carboxamide derivatives
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
NZ194557A (en) * 1979-08-17 1984-09-28 Merck & Co Inc Substituted pyranone derivatives;dihydroxy acids therefrom;pharmaceutical compositions
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
EP0068038B1 (en) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same
AU570021B2 (en) * 1982-11-22 1988-03-03 Novartis Ag Analogs of mevalolactone
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
PT77996B (en) * 1983-01-24 1986-05-30 Sandoz Sa Process of the preparations of mevalonelactone analogs and derivatives thereof and of pharmaceutical compositions containing them
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
CA1327360C (en) * 1983-11-14 1994-03-01 William F. Hoffman Oxo-analogs of mevinolin-like antihypercholesterolemic agents
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
JPS61502467A (ja) * 1984-06-22 1986-10-30 サンド・アクチエンゲゼルシヤフト メバロノラクトンのピラゾ−ル同族体およびその誘導体、それらの製造方法ならびに用途
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
US4621099A (en) * 1985-09-23 1986-11-04 Usv Pharmaceutical Corporation Polyene compounds useful in the treatment of allergic responses
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
AU601264B2 (en) * 1987-02-25 1990-09-06 Bristol-Myers Squibb Company Antihypercholesterolemic tetrazole compounds

Also Published As

Publication number Publication date
AU1213288A (en) 1988-09-01
FI96600B (sv) 1996-04-15
DK97388D0 (da) 1988-02-24
ES2009547A6 (es) 1989-10-01
SE503201C2 (sv) 1996-04-15
IT8819526A0 (it) 1988-02-24
LU87143A1 (fr) 1988-09-20
JPS63290872A (ja) 1988-11-28
FR2611201A1 (fr) 1988-08-26
GB8804281D0 (en) 1988-03-23
FI880868A0 (sv) 1988-02-24
NZ223621A (en) 1991-06-25
ATA46088A (de) 1992-06-15
AT395588B (de) 1993-01-25
DE3805789C2 (de) 2001-05-31
CN1030077C (zh) 1995-10-18
MY102290A (en) 1992-05-15
GR880100100A (en) 1988-12-16
GB2202845B (en) 1991-05-22
SE9300977L (sv)
PT86821B (pt) 1992-05-29
IT1216752B (it) 1990-03-08
YU36488A (en) 1990-02-28
PT86821A (pt) 1988-03-01
HU201532B (en) 1990-11-28
GB2202845A (en) 1988-10-05
JP2603284B2 (ja) 1997-04-23
NO178432B (no) 1995-12-18
SE512485C2 (sv) 2000-03-20
CA1328269C (en) 1994-04-05
NO880802D0 (no) 1988-02-24
GR1000473B (el) 1992-07-30
FI880868A (sv) 1988-08-26
IE880502L (en) 1988-08-18
HU201533B (en) 1990-11-28
KR960007167B1 (ko) 1996-05-29
YU46781B (sh) 1994-05-10
IE61608B1 (en) 1994-11-16
KR880009946A (ko) 1988-10-06
DK97388A (da) 1988-08-26
FR2611201B1 (fr) 1991-01-11
FI96600C (sv) 1996-07-25
HUT47258A (en) 1989-02-28
AU610562B2 (en) 1991-05-23
SE8800637L (sv) 1988-08-26
NO880802L (no) 1988-08-26
SE9300976D0 (sv) 1993-03-24
NO178432C (no) 1996-03-27
CH678182A5 (sv) 1991-08-15
BE1002115A3 (fr) 1990-07-10
DE3805789A1 (de) 1988-09-15
SE9300976L (sv) 1993-03-24
SE504553C2 (sv) 1997-03-03
US4898949A (en) 1990-02-06
SE8800637D0 (sv) 1988-02-24
NL8800468A (nl) 1988-09-16
HU201534B (en) 1990-11-28
CN1070642A (zh) 1993-04-07
HU895124D0 (sv) 1990-01-28
DK113897A (da) 1997-10-06

Similar Documents

Publication Publication Date Title
ATE195938T1 (de) 2-(1',2',4'-triazol-3'yloxymethylen)-anilide und ihre verwendung als schädlingsbekämpfungsmittel
MX9300821A (es) Compuestos hipolipidemicos.
HUP0203288A2 (hu) Foszfodiészteráz VII inhibitor hatású pirrolszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE69231445T2 (de) Triazole enthaltende antifungizide mittel
DE69131325D1 (de) Zwischenverbindungen zur herstellung von thioalkylthio cephalosporinderivaten
DE69317439D1 (de) Azoxycyanbenzol-Derivate
DK0754682T3 (da) Aminostilbazolderivat og lægemiddel
FI954016A0 (sv) Nya föreningar
ATE9474T1 (de) Cephalosporinverbindungen und ihre herstellung.
SE9300977D0 (sv) Foerfarande foer framstaellning av mellanprodukter avsedda foer framstaellning av antihyperkolesterolemiska medel
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
ATE46159T1 (de) Pyridazinone, inotrope mittel.
SE8001556L (sv) Tetrahydrobensotiazolylimidazolidinoner
DK0449515T3 (da) Hidtil ukendte cephalosporin-mellemprodukter og fremgangsmåde til fremstilling af mellemprodukterne og slutprodukter deraf
FI933755A (fi) Foerfarande foer framstaellning av trans-piperidin-2,5-dikarboxylater
ATE39682T1 (de) Derivate von 3-phenyl-2-propenamin, ihre herstellung und diese enthaltende arzneimittel.
EP0028936A3 (en) 4-carbamoylimidazol-5-ol derivatives, their production and pharmaceutical compositions containing them
ES8502699A1 (es) Procedimiento para la obtencion de tetrahidrotiopiran-3, 5-dion-4-carboxamidas
DK165592C (da) Benzoylurinstofforbindelser, fremgangsmaade til fremstilling deraf, pesticidt praeparat indeholdende saadan forbindelse samt fremgangsmaade til bekaempelse af skadelige organismer
ATE284379T1 (de) Aminderivate
DE3873046D1 (de) N-phenyltetrahydrophthalimide.
DK0532725T3 (da) Isoxazolderivater som lysfilterpræparater
YU13197A (sh) Novi 2,3-benzodiazepinski derivati, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže

Legal Events

Date Code Title Description
NUG Patent has lapsed